Winston Medical Supply Co., Ltd. (TPEX:6817)

Taiwan · Delayed Price · Currency is TWD

48.85

-0.15 (-0.31%)

Aug 19, 2026, 1:25 PM CST

-54.98% (1Y)

Market Cap	992.68M -51.4%
Revenue (ttm)	632.80M -12.6%
Net Income	82.47M -38.6%
EPS	4.47 -38.4%
Shares Out	18.42M
PE Ratio	12.05
Forward PE	n/a
Dividend	5.00 (10.20%)
Ex-Dividend Date	Jun 16, 2026

Volume	4,356
Open	48.90
Previous Close	49.00
Day's Range	46.85 - 48.90
52-Week Range	47.35 - 114.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Winston Medical Supply

Winston Medical Supply Co., Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, ch... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1974

Employees 180

Stock Exchange Taipei Exchange

Ticker Symbol 6817

Full Company Profile

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.

Financial Statements